Moolec Science S.A.
MLECNASDAQHealthcare● Active
$7.14
$-0.33(-4.42%)
Market Cap$5184483
P/E Ratio—
52W High$120
52W Low$3.075
Moolec Science S.A. (MLEC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MLEC · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2025Report Date: Oct 1, 2025EPS Actual
-$0.70
Est. -$0.70 · +0.0%
Revenue
—
Est. $0.00B
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Oct 1, 2025
After Market Close
✓ 1-Quarter EPS Beat Streak
MLEC reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.02
Rev. $0.33B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.02
Rev. Est.$0.33B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | May 14, 2026 | -$10.50 | — | — | — | $0.00B | — |
| ◌ Q1 FY2026 | Mar 11, 2026 | — | — | — | — | — | — |
| — Q4 FY2025 | Oct 1, 2025 | -$0.70 | -$0.70 | +0.0% | — | $0.00B | — |
| ▼ Q3 FY2025 | Jul 2, 2025 | -$9.00 | -$10.50 | -16.7% | $0.00B | $0.00B | +29.3% |
| ▲ Q2 FY2025 | Apr 16, 2025 | -$10.50 | -$9.00 | +14.3% | $0.00B | $0.00B | +14.3% |
| — Q2 FY2025 | Apr 10, 2025 | — | -$0.93 | — | $0.00B | $0.00B | +101.0% |
| ▼ Q4 FY2024 | Oct 2, 2024 | -$0.07 | -$10.49 | -14885.7% | $0.00B | $0.00B | +32.9% |
| — Q2 FY2024 | Jun 30, 2024 | — | -$1.05 | — | $0.00B | — | — |
Q2 FY2026
May 14, 2026
EPS Actual
—
EPS Est.
-$10.50
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 11, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Oct 1, 2025
EPS Actual
-$0.70
EPS Est.
-$0.70
EPS Surpr.
+0.0%
Revenue
—
Q3 FY2025
Jul 2, 2025Miss
EPS Actual
-$10.50
EPS Est.
-$9.00
EPS Surpr.
-16.7%
Revenue
$0.00B
Q2 FY2025
Apr 16, 2025Beat
EPS Actual
-$9.00
EPS Est.
-$10.50
EPS Surpr.
+14.3%
Revenue
$0.00B
Q2 FY2025
Apr 10, 2025
EPS Actual
-$0.93
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Oct 2, 2024Miss
EPS Actual
-$10.49
EPS Est.
-$0.07
EPS Surpr.
-14885.7%
Revenue
$0.00B
Q2 FY2024
Jun 30, 2024
EPS Actual
-$1.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $-10.50 | $-10.50 | $-10.50 | 1 |
| Q4 FY2027 | $-9.00 | $-9.00 | $-9.00 | 1 |
| Q3 FY2027 | $-9.00 | $-9.00 | $-9.00 | 1 |
| Q2 FY2027 | $-10.50 | $-10.50 | $-10.50 | 1 |
| Q1 FY2027 | $-9.00 | $-9.00 | $-9.00 | 1 |
| Q4 FY2026 | $-10.50 | $-10.50 | $-10.50 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2025 | Oct 1, 2025 | +0.0% | $14.71 | $13.95 | -5.17% |
| ▼ Q3 FY2025 | Jul 2, 2025 | -16.7% | $93.90 | $90.15 | -3.99% |
| ▲ Q2 FY2025 | Apr 16, 2025 | +14.3% | $107.82 | $106.50 | -1.22% |
| — Q2 FY2025 | Apr 10, 2025 | — | $96.30 | $93.41 | -3.00% |
| ▼ Q4 FY2024 | Oct 2, 2024 | -14885.7% | $127.50 | $135.00 | +5.88% |
| — Q2 FY2024 | Jun 30, 2024 | — | $165.00 | $166.52 | +0.92% |
| ▼ Q2 FY2024 | May 30, 2024 | -757.1% | $175.50 | $179.30 | +2.17% |
| ▲ Q1 FY2024 | Mar 13, 2024 | +0.0% | $249.00 | $244.50 | -1.81% |
Q4 FY2025-5.17%
Report Date
Oct 1, 2025
EPS Beat/Miss
+0.0%
Price Before
$14.71
Price After
$13.95
Q3 FY2025-3.99%
Report Date
Jul 2, 2025
EPS Beat/Miss
-16.7%
Price Before
$93.90
Price After
$90.15
Q2 FY2025-1.22%
Report Date
Apr 16, 2025
EPS Beat/Miss
+14.3%
Price Before
$107.82
Price After
$106.50
Q2 FY2025-3.00%
Report Date
Apr 10, 2025
EPS Beat/Miss
—
Price Before
$96.30
Price After
$93.41
Q4 FY2024+5.88%
Report Date
Oct 2, 2024
EPS Beat/Miss
-14885.7%
Price Before
$127.50
Price After
$135.00
Q2 FY2024+0.92%
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
$165.00
Price After
$166.52
Q2 FY2024+2.17%
Report Date
May 30, 2024
EPS Beat/Miss
-757.1%
Price Before
$175.50
Price After
$179.30
Q1 FY2024-1.81%
Report Date
Mar 13, 2024
EPS Beat/Miss
+0.0%
Price Before
$249.00
Price After
$244.50
Avg Beat Reaction-2.73%
Avg Miss Reaction+1.35%
Beat Rate3 / 8 quarters
Largest Move+5.88% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MLEC ends December
Moolec Science S.A. (MLEC) most recently reported earnings on October 1, 2025 for Q4 FY2025, posting EPS of $-0.70 (in line with the analyst consensus of $-0.70). The next MLEC earnings date is expected around September 1, 2026.
Each quarter, investors track MLEC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MLEC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MLEC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MLEC earnings · 4 questionsMoolec Science S.A.'s next earnings report is expected around September 1, 2026. MLEC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MLEC historically reports after market close (AMC).
MLEC earnings datewhen is MLEC earningsMLEC next earnings datewhen does MLEC report earningsMLEC earnings calendar
▸ Source: FMP · Moolec Science S.A. SEC filings · US GAAP · Moolec Science S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026